Analgesics in Morocco

September 2023 | 24 pages | ID: AD93479E5DEEN
Euromonitor International Ltd

Abstracts

Analgesics in Morocco has continued to develop positively in 2023, with total current value sales set to grow at a faster rate than in 2022 and most categories expected to post improved results in volume terms. Together with population growth and other favourable demographic trends, overall demand has been buoyed by the increasing willingness of consumers to self-medicate for mild-to-moderate pain and similarly minor ailments such as cold and flu symptoms.

Euromonitor International's Analgesics in Morocco report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Analgesics in Morocco
Euromonitor International
September 2023

LIST OF CONTENTS AND TABLES

ANALGESICS IN MOROCCO
KEY DATA FINDINGS

2023 DEVELOPMENTS

Self-medication and return to pre-pandemic routines boost overall demand
Demographic and lifestyle changes favour topical analgesics/anaesthetic category
Bottu’s Doliprane still the best-selling analgesics brand
PROSPECTS AND OPPORTUNITIES
Adult acetaminophen projected to record strongest growth in volume sales
Local brands and generics likely to make further gains
Analgesics should profit from efforts to stem misuse of antibiotics and corticosteroids
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2018-2023
Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN MOROCCO
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture

2023 KEY TRENDS

Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by: Value Category2018-2023
Table 10 Sales of Consumer Health by: % Value Growth Category2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Distribution of Consumer Health by Format: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format and Category: % Value 2023
Table 15 Forecast Sales of Consumer Health by: Value Category2023-2028
Table 16 Forecast Sales of Consumer Health by: % Value Growth Category2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources